Bmc Cancer
Overview
BMC Cancer is an open-access, peer-reviewed journal that focuses on all aspects of cancer research, including prevention, diagnosis, treatment, and survivorship. It publishes high-quality articles that contribute to the understanding of cancer biology, genetics, epidemiology, and clinical trials. With a multidisciplinary approach, BMC Cancer aims to advance knowledge and promote collaboration in the fight against cancer.
Details
Details
Abbr.
BMC Cancer
Publisher
Biomed Central
Start
2001
End
Continuing
e-ISSN
1471-2407
Country
United Kingdom
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 1242
160
SJR / Ranks: 3290
1087
CiteScore / Ranks: 3060
6.80
JIF / Ranks: 2461
3.8
Recent Articles
1.
Zhou N, Bai H, Zhang Z, Yu B, Zhao H, Li J, et al.
BMC Cancer
. 2025 Mar;
25(1):481.
PMID: 40089733
Background: Identifying the past and future burden of kidney cancer (KC) and its temporal trends among older adults (≥ 65 years) at global, regional, and national levels is critical for...
2.
Zhao J, Yang G, Li Y, Li S, Luo H, Han D, et al.
BMC Cancer
. 2025 Mar;
25(1):484.
PMID: 40089723
Background: Anastomotic leak (AL) is a common complication in patients with operable esophageal squamous cell carcinoma (ESCC) treated with neoadjuvant chemoradiotherapy (NCRT) and radical esophagectomy. Therefore, this study aimed to...
3.
Li Y, Liu Y, Xie Y, Wang Y, Wang J, Wang H, et al.
BMC Cancer
. 2025 Mar;
25(1):482.
PMID: 40089719
Background: Transposable elements (TEs), which constitute nearly half of the human genome, have long been regarded as genomic "dark matter". However, their reactivation in tumor cells, resulting in the production...
4.
Dincer B, Gok A, Ilhan M, Ercan L, Kulle C, Ercan C, et al.
BMC Cancer
. 2025 Mar;
25(1):479.
PMID: 40089698
Background: Cytoreductive Surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are techniques developed for curative treatment of peritoneal carcinomatosis (PC). Studies have shown that CRS + HIPEC provides a survival advantage...
5.
Wang Y, Yang Z, Li Z, Huang L, Hou S, Wang J, et al.
BMC Cancer
. 2025 Mar;
25(1):480.
PMID: 40089671
Background: This study aimed to identify molecular markers that influence liver metastasis in colorectal cancer (CRC) and assess their clinical relevance. Methods: Proteomic analysis compared differential protein expression between CRC...
6.
Roux A, Hervouet L, Stefano F, French D, Giordano L, Ritchie D, et al.
BMC Cancer
. 2025 Mar;
25(1):483.
PMID: 40089664
Background: To evaluate the acceptability of a risk-based breast cancer screening (BCS) strategy among professionals involved in MyPeBS study in 6 countries. Methods: After qualitative interviews, a questionnaire was built...
7.
Li Y, Tong Z, Yang Y, Wang Y, Wen L, Li Y, et al.
BMC Cancer
. 2025 Mar;
25(1):478.
PMID: 40089661
Background: Lung cancer remains a leading cause of cancer-related mortality, primarily because of the lack of effective diagnostic and therapeutic biomarkers. To address the issue of fragmented biomarker data across...
8.
Chen Y, Hu R, Jin C, Huang L, Lin Y, Zou B, et al.
BMC Cancer
. 2025 Mar;
25(1):469.
PMID: 40087677
Objectives: To evaluate the safety and efficacy of ultrasound (US)-guided microwave ablation (MWA) for inactivating excess remnant thyroid (RT) after surgery in patients with differentiated thyroid cancer (DTC). Methods: This...
9.
Yao Z, Qin D, Cao J, Gao C, Xi P, Li S, et al.
BMC Cancer
. 2025 Mar;
25(1):476.
PMID: 40087664
Background: Conventional epidemiological studies have reported inconsistent results regarding the potential adverse effects of long-term use of antihypertensive drugs on cancer risk. Nevertheless, evidence of their impact on pancreatic cancer...
10.
Sheng Z, Xu J, Wang M, Xu X, Zhu J, Zeng S, et al.
BMC Cancer
. 2025 Mar;
25(1):468.
PMID: 40087655
Background: Bladder cancer (BCa) is a common urinary malignancy with high recurrence rates in non-muscle invasive bladder cancer (NMIBC), posing significant clinical challenges. Emerging evidence links urinary microbiota to cancer...